November 1, 2021
Regenerative technology uncovers new discoveries in liver disease
Mayo Clinic researchers have developed a method for generating bile duct cells from stem cells. This technology enables them to study important aspects of primary sclerosing cholangitis, a rare bile duct disease that often destroys the liver. Using these regenerative technologies, Robert Huebert, M.D., and Nidhi Jalan Sakrikar, Ph.D., also confirmed that primary sclerosing cholangitis […]
Tags: bile ducts, Center for Regenerative Medicine, liver disease, Nidhi Jalan Sakrikar, Robert Huebert
October 4, 2019
Chemo first for better outcomes in bile duct cancer, says new research
Oncology care teams frequently use chemotherapy along with surgery to treat cholangiocarcinoma, or bile duct cancer. However, until now, little evidence existed regarding if and when receiving chemotherapy was likely to have the best effect. Recently Mayo Clinic researchers found that patients who received chemotherapy before surgery to remove their bile duct cancer were more […]
Tags: Amit Mahipal, bile ducts, cancer, Center for the Science of Health Care Delivery, chemotherapy, cholangiocarcinoma, gastrointestinal cancer, hematology, Mayo Clinic Cancer Center, oncology, rare disease, Siddhartha Yadav
May 9, 2019
How can we get better outcomes for our patients? Research.
In the Mayo Clinic Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, every project is inspired by real-world challenges experienced by patients at Mayo Clinic and elsewhere. Together with Mayo Clinic’s health care providers, center experts research ways to improve outcomes for patients across all of medicine, from Alzheimer’s […]
Tags: bile ducts, cancer, care transitions, Center for the Science of Health Care Delivery, ICU, intensive care unit, Mayo Clinic Cancer Center, multiple chronic conditions, readmissions, surgery